Abstract
Background The insula is a heterogeneous cortical region with three cytoarchitectural subregions— agranular, dysgranular, and granular—that have distinct functional roles. Previous cross- sectional studies have shown smaller volume of all insula subregions in individuals with psychotic disorders. However, longitudinal trajectories of insula subregions in early psychosis, and the relationship between subregional volumes and relevant clinical phenomena, such as perceptual aberrations, have not been previously examined.
Methods 66 early psychosis (EP) and 65 healthy comparison (HC) participants completed 2-4 study visits over 2 years. T1-weighted structural brain images were processed using longitudinal voxel- based morphometry in CAT12 and segmented into anatomic subregions. At baseline, participants completed the Perceptual Aberrations Scale (PAS) to capture bodily distortions. The EP group was further examined based on diagnostic trajectory over two years (stable schizophrenia, stable schizophreniform, and conversion from schizophreniform to schizophrenia).
Results EP participants had smaller insula volumes in all subregions compared to HC participants, and these volumes were stable over two years. Compared to HC, insula volumes were significantly smaller in EP participants with a stable diagnosis of schizophrenia, but other diagnostic trajectory groups did not significantly differ from HC or the stable schizophrenia group. While perceptual aberrations were significantly elevated in EP participants, PAS scores were not significantly related to insula volume.
Conclusions We find that all insula subregions are smaller in early psychosis and do not significantly decline over two years. These data suggest that all insula subregions are structurally impacted in schizophrenia-spectrum disorders and may be the result of abnormal neurodevelopment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work outlined in this manuscript was supported by the Charlotte and Donald Test Fund, NIMH grants R01-MH70560 (Heckers) R01-MH123563 (Vandekar), the Jack Martin, MD Research in Psychopharmacology endowment (Sheffield) and K23-MH126313. This work was conducted in part using the resources of the Center for Computational Imaging at the Vanderbilt University Institute of Imaging Sciences and the Advanced Computing Center for Research and Education (ACCRE) at Vanderbilt University in Nashville, TN.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Vanderbilt University Institutional Review Board (IRB #080606, PI: S.H.).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.